TipRanks
Go Ultimate55% OFF

Novavax (NVAX) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

NVAX Analyst Ratings

Hold
4Ratings
1Buy1Hold2Sell
Based on 4 analysts giving stock ratings to Novavax in the past 3 months

NVAX Stock 12 Month Forecast

MXN 200.62▲(6.15% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Novavax in the last 3 months. The average price target is MXN 200.62 with a high forecast of MXN 335.93 and a low forecast of MXN 149.30. The average price target represents a 6.15% change from the last price of MXN 189.00.
Highest Price TargetMXN 335.93Average Price TargetMXN 200.62Lowest Price TargetMXN 149.30

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:NVAX
Price TargetFollowArticle
Cantor FitzgeraldMXN 335.93buy77.74%UpsideAssigned10/26/26
Bank of America SecuritiesMXN 130.64→MXN 149.30sell-21.00%DownsideReiterated10/23/26
CitiMXN 130.64→MXN 149.30sell-21.00%DownsideReiterated10/16/26
TD CowenMXN 167.96hold-11.13%DownsideAssigned08/04/26
BTIGMXN 354.59buy87.61%UpsideReiterated06/11/26
H.C. WainwrightMXN 298.60buy57.99%UpsideReiterated04/21/26
B. Riley SecuritiesMXN 298.60→MXN 335.93buy77.74%UpsideReiterated04/09/26
J.P. MorganMXN 130.64→MXN 111.98sell-40.75%DownsideReiterated11/18/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novavax

3 Months
Alec Stranahan
Alec StranahanBank of America Securities
Success Rate13/22 ratings generated profit
59%
Average Return
+8.80%

Copying Alec Stranahan's trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +8.80% per trade.

1 Year
Alec Stranahan
Alec StranahanBank of America Securities
Success Rate8/22 ratings generated profit
36%
Average Return
-2.94%

Copying Alec Stranahan's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of -2.94% per trade.

2 Years
Mayank Mamtani
Mayank MamtaniB. Riley Securities
Success Rate9/27 ratings generated profit
33%
Average Return
-35.01%

Copying Mayank Mamtani's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -35.01% per trade.

NVAX Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for NVAX
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy31212
Buy00000
Hold11111
Sell22235
Strong Sell00000
total64558

In the current month, NVAX has received 2 Buy Ratings, 1 Hold Ratings, and 5 Sell Ratings. NVAX average Analyst price target in the past 3 months is 200.62.

NVAX Financial Forecast

MXN -25MXN -18MXN -11MXN -4MXN 3Q4 2025Q2 2026Q3 2026
HighMXN -4.36
ConsensusMXN -6.50
LowMXN -9.21

NVAX Earnings Forecast

Next quarter’s earnings estimate for NVAX is -MXN 6.50 with a range of -MXN 9.21 to -MXN 4.36. The previous quarter’s EPS was -MXN 6.01. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

MXN 621.7MMXN 1.2BMXN 1.7BMXN 2.2BMXN 2.8BQ4 2025Q2 2026Q3 2026
HighMXN 1.31B
ConsensusMXN 947M
LowMXN 622M

NVAX Sales Forecast

Next quarter’s sales forecast for NVAX is MXN 947.25M with a range of MXN 621.71M to MXN 1.31B. The previous quarter’s sales results were MXN 1.07B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NVAX Stock Forecast FAQ

What is MX:NVAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Novavax’s 12-month average price target is Mex$200.62.
What is MX:NVAX’s upside potential, based on the analysts’ average price target?
Novavax has 6.15% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novavax a Buy, Sell or Hold?
Novavax has a consensus rating of Hold, which is based on 1 buy ratings, 1 hold ratings and 2 sell ratings.
What is Novavax’s share price target?
The average share price target for Novavax is Mex$200.62. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$335.93, and the lowest forecast is Mex$149.30. The average share price target represents a 6.15% increase from the current price of Mex$189.
What do analysts say about Novavax?
Novavax’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Novavax?
To buy shares of MX:NVAX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.